Revenues (Tables)

3 Months Ended

Mar. 31, 2018

Revenue from Contract with Customer [Abstract]

Schedule of New Accounting Pronouncements and Changes in Accounting Principles

See the impacts to reported results below for the impact of adoption of the Topic 606 on our consolidated financial statements (in thousands):



	December 31, 2017 (As reported)		Impact of Adoption of Topic 606 on Opening Balance Sheet			January 1, 2018 (As adjusted)
Accounts and notes receivable, net	$	56,064	$	28,915		$	84,979
Contract assets, net	—		5,512			5,512
Prepaid expense and other current assets	21,696		2,003			23,699
Total impacted current assets	77,760		36,430			114,190
Deferred income tax assets, net	15,755		(5,158		)	10,597
Long-term notes receivable, net of current portion	36,877		(12,977		)	23,900
Other assets	15,366		5,323			20,689
Total impacted assets	145,758		23,618			169,376

Accrued liabilities	23,502		2,512			26,014
Current portion of deferred revenue	70,401		863			71,264
Total impacted current liabilities	93,903		3,375			97,278
Deferred revenue, net of current portion	54,881		1,249			56,130
Total impacted liabilities	148,784		4,624			153,408
Retained earnings	123,185		18,994			142,179
Total impacted stockholders' equity	123,185		18,994			142,179
Total impacted liabilities and stockholders' equity	271,969		23,618			295,587

Summary of Revenue by Product and Service Offering and Geography

The following table presents the Company's revenues by primary product and service offering (in thousands):



	Three Months Ended March 31, 2018						Three Months Ended March 31, 2017 ⁽¹⁾
	TASER Weapons		Software and Sensors		Total		TASER Weapons		Software and Sensors		Total
TASER X26P	$	16,474	$	—	$	16,474	$	15,668	$	—	$	15,668
TASER X2	23,932		—		23,932		18,986		—		18,986
TASER Pulse and Bolt	1,346		—		1,346		1,022		—		1,022
Single cartridges	16,114		—		16,114		16,664		—		16,664
Axon Body	—		5,558		5,558		—		3,446		3,446
Axon Flex	—		1,669		1,669		—		1,475		1,475
Axon Dock	—		3,035		3,035		—		1,987		1,987
Axon Fleet	—		2,116		2,116		—		—		—
Evidence.com	—		20,241		20,241		—		11,742		11,742
TASER Cam	—		1,360		1,360		—		719		719
Extended warranties	3,706		2,490		6,196		2,843		1,418		4,261
Other	1,952		1,222		3,174		2,488		784		3,272
Total	$	63,524	$	37,691	$	101,215	$	57,671	$	21,571	$	79,242

⁽¹⁾ Amounts for the three months ended March 31, 2017 have not been adjusted under the modified retrospective method of adoption of Topic 606, and are presented consistent with the prior period amounts reported under ASC 605.

The following table presents the Company's revenues disaggregated by geography (in thousands):



	Three Months Ended March 31,
	2018				2017 ⁽¹⁾
United States	$	77,950	77	%	$	64,752	82	%
Other countries	23,265		23		14,490		18
Total	$	101,215	100	%	$	79,242	100	%

Contract with Customer, Assets and Liabilities

Contract liabilities (deferred revenue) consisted of the following (in thousands):



	March 31, 2018						December 31, 2017 ⁽¹⁾
	Current		Long-Term		Total		Current		Long-Term		Total
Warranty:
TASER Weapons	$	11,601	$	17,058	$	28,659	$	12,501	$	18,619	$	31,120
Software and Sensors	6,941		5,660		12,601		6,293		4,195		10,488
	18,542		22,718		41,260		18,794		22,814		41,608
Hardware:
TASER Weapons	4,283		12,440		16,723		4,164		11,401		15,565
Software and Sensors	14,152		15,197		29,349		16,956		14,781		31,737
	18,435		27,637		46,072		21,120		26,182		47,302
Software and Sensors Services	39,164		7,648		46,812		30,487		5,885		36,372
Total	$	76,141	$	58,003	$	134,144	$	70,401	$	54,881	$	125,282



	March 31, 2018						December 31, 2017 ⁽¹⁾
	Current		Long-Term		Total		Current		Long-Term		Total
TASER Weapons	$	15,884	$	29,498	$	45,382	$	16,665	$	30,020	$	46,685
Software and Sensors	60,257		28,505		88,762		53,736		24,861		78,597
Total	$	76,141	$	58,003	$	134,144	$	70,401	$	54,881	$	125,282

⁽¹⁾ Amounts as of December 31, 2017 have not been adjusted under the modified retrospective method of adoption of Topic 606, and are presented consistent with the prior period amounts reported under ASC 605.

The following table presents the Company's contract assets, contract liabilities and certain information related to these balances as of and for the three months ended March 31, 2018 (in thousands):



	March 31, 2018
Contract assets	$	9,278
Contract liabilities (deferred revenue)	134,144
Revenue recognized in the period from:
Amounts included in contract liabilities at the beginning of the period	24,269

Capitalized Contract Cost

As of March 31, 2018, the Company's assets for costs to obtain contracts were as follows (in thousands):



	March 31, 2018
Current deferred commissions ⁽¹⁾	$	5,526
Deferred commissions, net of current portion ⁽²⁾	12,881
	$	18,407

⁽¹⁾ Current deferred commissions are included within "Prepaid expenses and other current assets" on the accompanying condensed consolidated balance sheet.

⁽²⁾Deferred commissions, net of current portion, are included in "Other assets" on the accompanying condensed consolidated balance sheet.